THERMOSAFE acquired by ARSENAL CAPITAL PARTNERS
Context
Arsenal Capital Partners completed the acquisition of ThermoSafe from Sonoco Products Company. The deal represents a full‑control buy‑out of ThermoSafe, with the seller exiting the cold‑chain packaging segment and simplifying its portfolio around core metal and paper consumer and industrial packaging businesses. The temperature‑controlled packaging business is deeply embedded in the pharmaceutical and biologics value chain, serving high‑value, highly regulated shipments where product integrity and temperature control are critical. Arsenal positions the transaction as a strategic platform play within its middle‑market specialty‑industrial and healthcare vertical, aiming to leverage its prior experience in the packaging and industrial materials sectors to accelerate ThermoSafe’s growth through expanded geographic reach, product‑line innovation, and operational improvements. The firm also plans to support the existing management team led by CEO Russell Grissett, reinforcing continuity while professionalizing governance and commercial capabilities to capture further share in a global cold‑chain packaging market projected to grow at a double‑digit CAGR over the next decade.
THERMOSAFE, which reported an EBITDA margin of in 2024, is valued in this transaction at an EV/EBITDA multiple of , representing a to the average currently observed in the Industry & Manufacturing sector (11.6x).
-> Deep-dive in Industry & Manufacturing market trends
Target
ThermoSafe is a specialty industrial company that provides temperature‑controlled packaging systems for the transportation of pharmaceuticals, biologics, vaccines, and clinical supplies. Headquartered in Arlington Heights, Illinois, near Chicago, the group operates additional facilities in France, India, and Brazil, giving it a transatlantic and emerging‑market footprint aligned with global healthcare logistics. The company’s product portfolio includes parcel shippers for single‑ and multi‑dose medications, reusable shippers for repeated cold‑chain use, and bulk transport systems for pallet‑sized, temperature‑assured shipments, all engineered to maintain precise refrigerated, frozen, and controlled room‑temperature conditions throughout the supply chain. ThermoSafe also offers design, testing, and regulatory compliance services through its ISC Labs division, enabling customers to validate and optimize packaging for complex life‑science applications.
Ent. Value
Equity Value
Multiples
EV / Revenue
EV / EBITDA
EV / EBIT
Historical Financials (USD)
Similar deals in Chemicals & Materials
| Date | Acquirer | Target | Country | Sector |
|---|---|---|---|---|
| 12/2025 | MOSAIQ GROUP | REDMARK | ITALY | Paper & Cardboard |
| 12/2025 | STONEPEAK | CASTROL | UNITED KINGDOM | Specialty Chemicals |
| 11/2025 | BPIFRANCE / BNP PARIBAS DEVELOPPEMENT | SACRED | FRANCE | Plastics |
| 11/2025 | KPS CAPITAL PARTNERS | NOVACEL | FRANCE | Plastics |
| 11/2025 | COIM GROUP | NOTEDOME | UNITED KINGDOM | Plastics |
| 11/2025 | ARCOLE / BENALU-LEGRAS | METHAL | FRANCE | Metallurgy / Foundry |
| 09/2025 | FRENCH FOOD CAPITAL | SOPANO | FRANCE | Labels & Adhesives |
| 07/2025 | UNIGASKET | ASSOTECH | ITALY | Plastics |
| 07/2025 | NORCROS | FIBO GROUP | NORWAY | Wall & Ceiling Systems |
| 05/2025 | MOVENDO CAPITAL / DRAYCOTT | VERESCENCE | FRANCE | Glass Packaging |
REFERENCES
Valuation range: EV 500M - 1.5b USD
Revenue range: 150M - 250M USD
EBITDA range: 50M - 100M USD
Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of THERMOSAFE by ARSENAL CAPITAL PARTNERS are reserved for mynth community members. Register for free to unlock full data.
Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.
Press release: view release
Acquirer: arsenal capital partners